While pneumonitis was the major cause (35%) of all fatal irAEs in patients on PD-1 inhibitors, 70% of fatal irAEs in patients treated with the combination therapy (PD-1/PD-L1 plus CTLA-4 inhibitors) were due to colitis. The gene discussed is PDCD1; the disease is pneumonitis.